BridgeBio Pharma, Inc.
BBIO· Nasdaq
BBIOBridgeBio Pharma, Inc.
Quarterly figures for BridgeBio Pharma, Inc., with source filings when available.
32 quarters. Sep 30, 2018 to Jun 30, 2026. USD.
BridgeBio Pharma, Inc. has filed its 10-Q within 29 to 43 days of period end across its last 8 quarters. The 10-K runs 51 to 63 days.
BridgeBio Pharma, Inc. · CIK 1743881 · Engraved from SEC EDGAR
| Period | Ended | Announced | Filed | Lag | Form | Revenue | Δ yoy | EPS dil. | Source trail |
|---|---|---|---|---|---|---|---|---|---|
| FY 2026 | |||||||||
| Q2 2026 | Jun 30, 2026 | Aug 10, 2026 · after-hours | Aug 10, 2026 | 41 d | 10-Q | $243.68M | +120.4% | -$0.78 | |
| Q1 2026 |
|---|
| Mar 31, 2026 |
| May 7, 2026 · after-hours |
| May 7, 2026 |
| 37 d |
| 10-Q |
| $194.52M |
| +66.8% |
| -$0.84 |
| FY 2025 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2025derived | Dec 31, 2025 | Feb 24, 2026 · after-hours | Feb 24, 2026 | 55 d | 10-K | $154.18M | +2,521.2% | — | |
| Q3 2025 | Sep 30, 2025 | Oct 29, 2025 · after-hours | Oct 29, 2025 | 29 d | 10-Q | $120.70M | +4,318.0% | -$0.95 | |
| Q2 2025 | Jun 30, 2025 | Aug 5, 2025 · after-hours | Aug 5, 2025 | 36 d | 10-Q | $110.57M | +4,999.9% | -$0.95 | |
| Q1 2025 | Mar 31, 2025 | Apr 29, 2025 · after-hours | Apr 29, 2025 | 29 d | 10-Q | $116.63M | −44.8% | -$0.88 | |
| FY 2024 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2024derived | Dec 31, 2024 | Feb 20, 2025 · pre-market | Feb 20, 2025 | 51 d | 10-K | $5.88M | +237.1% | — | |
| Q3 2024 | Sep 30, 2024 | Nov 12, 2024 · pre-market | Nov 12, 2024 | 43 d | 10-Q | $2.73M | −33.2% | -$0.86 | |
| Q2 2024 | Jun 30, 2024 | Aug 1, 2024 · pre-market | Aug 1, 2024 | 32 d | 10-Q | $2.17M | +32.1% | -$0.39 | |
| Q1 2024 | Mar 31, 2024 | May 2, 2024 · pre-market | May 2, 2024 | 32 d | 10-Q | $211.12M | +11,461.9% | -$0.20 | |
| FY 2023 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2023derived | Dec 31, 2023 | Feb 22, 2024 · pre-market | Feb 22, 2024 | 53 d | 10-K | $1.75M | −6.7% | — | |
| Q3 2023 | Sep 30, 2023 | Nov 2, 2023 · pre-market | Nov 2, 2023 | 33 d | 10-Q | $4.09M | +1,110.4% | -$1.08 | |
| Q2 2023 | Jun 30, 2023 | Aug 3, 2023 · pre-market | Aug 3, 2023 | 34 d | 10-Q | $1.64M | −97.8% | -$0.98 | |
| Q1 2023 | Mar 31, 2023 | May 4, 2023 · pre-market | May 4, 2023 | 34 d | 10-Q | $1.83M | +7.8% | -$0.92 | |
| FY 2022 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2022derived | Dec 31, 2022 | Feb 23, 2023 · pre-market | Feb 23, 2023 | 54 d | 10-K | $1.87M | −85.5% | — | |
| Q3 2022 | Sep 30, 2022 | Nov 3, 2022 · after-hours | Nov 3, 2022 | 34 d | 10-Q | $338.00K | −85.6% | -$0.93 | |
| Q2 2022 | Jun 30, 2022 | Aug 4, 2022 · after-hours | Aug 4, 2022 | 35 d | 10-Q | $73.75M | +36.5% | -$0.07 | |
| Q1 2022 | Mar 31, 2022 | — | May 5, 2022 | 35 d | 10-Q | $1.69M | +266.7% | -$1.35 | |
| FY 2021 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2021derived | Dec 31, 2021 | Feb 24, 2022 · pre-market | Feb 25, 2022 | 56 d | 10-K | $12.89M | — | — | |
| Q3 2021 | Sep 30, 2021 | Nov 4, 2021 · pre-market | Nov 4, 2021 | 35 d | 10-Q | $2.34M | −71.2% | -$1.06 | |
| Q2 2021 | Jun 30, 2021 | — | Aug 5, 2021 | 36 d | 10-Q | $54.02M | — | -$0.66 | |
| Q1 2021 | Mar 31, 2021 | — | May 6, 2021 | 36 d | 10-Q | $462.00K | — | -$1.18 | |
| FY 2020 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2020derived | Dec 31, 2020 | — | Feb 25, 2021 | 56 d | 10-K | — | — | — | |
| Q3 2020 | Sep 30, 2020 | Nov 5, 2020 · pre-market | Nov 5, 2020 | 36 d | 10-Q | $8.13M | −69.6% | -$0.98 | |
| Q2 2020 | Jun 30, 2020 | Aug 11, 2020 · pre-market | Aug 11, 2020 | 42 d | 10-Q | — | — | -$1.03 | |
| Q1 2020 | Mar 31, 2020 | May 13, 2020 · after-hours | May 14, 2020 | 44 d | 10-Q | — | — | -$0.78 | |
| FY 2019 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2019derived | Dec 31, 2019 | Mar 2, 2020 · pre-market | Mar 3, 2020 | 63 d | 10-K | — | — | — | |
| Q3 2019 | Sep 30, 2019 | — | Nov 8, 2019 | 39 d | 10-Q | $26.74M | — | -$0.51 | |
| Q2 2019 | Jun 30, 2019 | — | Aug 14, 2019 | 45 d | 10-Q | — | — | -$0.71 | |
| Q1 2019 | Mar 31, 2019 | — | — | — | — | — | — | -$0.66 | |
| FY 2018 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2018derived | Dec 31, 2018 | — | — | — | — | — | — | — | |
| Q3 2018 | Sep 30, 2018 | — | — | — | — | — | — | -$0.52 | |
